Muscle spasticity, a common symptom of multiple sclerosis (MS), can make everyday movements feel stiff, tight, and painful. Stretching is one way to help reduce some of that discomfort, improve ...
A new study found smoking cannabis reduced spasticity in MS patients. May 14, 2012— -- Smoking marijuana may reduce certain symptoms in patients with multiple sclerosis, according to a new small ...
Dec. 5 -- FRIDAY, Dec. 4 (HealthDay News) -- Cancer patients, glaucoma patients and others can benefit from medical marijuana, and now a new analysis shows that it can help multiple sclerosis (MS) ...
Medicinal cannabinoids are helpful for treatment of spasticity, pain, and bladder dysfunction for patients with multiple sclerosis (MS), although their efficacy is "limited," new research suggests.
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) said Tuesday that phase 3 RELEASE MSS1 trial, which evaluated nabiximols oromucosal spray on clinical measures of spasticity in individuals with multiple ...
This transcript has been edited for clarity. Anne Cross, MD: Hello. I'm Anne Cross. Welcome to Medscape's InDiscussion series on multiple sclerosis. And today we're going to take on the somewhat ...
The spasticity treatment pipeline is rapidly evolving to meet the need for safer, longer-lasting, and more targeted therapies. Common in conditions like cerebral palsy, MS, stroke, and spinal injuries ...
LONDON – GW Pharma plc delivered positive results in a UK Phase III postmarketing study of Sativex, which will provide ballast for the launch of the cannabis-based product as a treatment for ...
DUBLIN, June 28, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 3 RELEASE MSS1 trial (NCT04657666) evaluating nabiximols oromucosal spray ...
Multiple sclerosis (MS) hip pain and knee soreness are very common problems. Joint issues are usually due to a nerve-related or muscle-related manifestation of MS rather than degeneration of cartilage ...
"Spasticity Pipeline Insight"The spasticity treatment pipeline is rapidly evolving to meet the need for safer, longer-lasting, and more targeted therapies. Common in conditions like cerebral palsy, MS ...